Statement by the South Centre to the Thirty-sixth Session of the Committee on Development and Intellectual Property (CDIP)
Geneva, 4 May 2026
The South Centre just delivered its statement to the 36th Session of WIPO’s Committee on Development and Intellectual Property (CDIP/36) in Geneva. The WIPO Development Agenda turns 20 next year, yet its transformative promise remains unfulfilled. A small number of Member States continue to block progress towards streamlining development in WIPO activities and operationalizing TRIPS flexibilities. Achieving SDGs should be an integral part of WIPO’s mandate legally grounded in the UN-WIPO Agreement.
Three Decades of Global Engagement: The South Centre’s Contribution to Intellectual Property and Development
By Nirmalya Syam
South Centre 30th Anniversary Series No. 2, 30 April 2026
This paper is part of a series of publications made in commemoration of the 30th anniversary of the South Centre, an intergovernmental organization established in 1995 to advance the interests of developing countries in global governance. Tracing its origins to the 1990 South Commission, it examines the Centre’s pivotal role in shaping intellectual property (IP) policies to promote equitable development. Through rigorous research, advocacy, and technical assistance, the South Centre has supported negotiations at the World Intellectual Property Organization (WIPO) and World Trade Organization (WTO), influencing milestones like the 2007 WIPO Development Agenda and extensions of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) transition periods for least developed countries.
Key contributions include promoting TRIPS flexibilities for public health, biodiversity, and technology transfer, with seminal publications on compulsory licensing, patent examination, and traditional knowledge protection. During the COVID-19 pandemic, the Centre advocated for IP waivers to enhance access to vaccines and therapeutics. Impacts include empowering Global South nations to implement development-oriented IP strategies and reform patent laws. Looking ahead, the paper addresses challenges from digital transformation, artificial intelligence (AI), and data governance, calling for strengthened South-South cooperation and proactive advocacy to ensure inclusive IP frameworks. The South Centre remains essential for fostering sustainable development and reducing global inequalities.
UK–India CETA: Patents and International Intellectual Property Governance
By Pratyush Nath Upreti & Virender Chandel
This policy brief locates the United Kingdom-India Comprehensive and Economic Trade Agreement’s (CETA) intellectual property rights (IPRs) rules in the midst of trade-offs. It succinctly provides an overview of the IPR Chapter, analyses the specific provisions on patents and contextualises IP in the broader context of international IP governance. The analysis of the IPR Chapter shows the parties’ objective to establish meaningful commitments on intellectual property protection and enforcement while preserving regulatory flexibility on development-centric and public health priorities. All in all, the IPR Chapter reflects a compromise between a country with an established, strong IP regime and a country seeking greater policy space and advancing IP norms in areas such as traditional knowledge. As India continues integrating into the global trade architecture through bilateral agreements, the CETA IPR Chapter will serve as a critical test case for whether strategic policy space can be meaningfully preserved within contemporary trade frameworks.
Evidence of Partnerships in the Cuban Pharmaceutical Sector
By Graziela Ferrero Zucoloto
This article analyzes the pharmaceutical partnership agreements of Cuban institutions. It identifies various partnerships with national and foreign firms that spanned 17 countries, with several developed nations appearing as recipients of Cuban technologies, and with Cuban institutions acting as the primary technology holder and licensor in the majority of agreements identified. These findings suggest that Cuba’s state-directed pharmaceutical model has produced an active, innovation-generating sector, with potential lessons for other countries, including Brazil, that maintain public pharmaceutical laboratories.
Statement by the South Centre to the WIPO Assemblies on the Reappointment of the Director General, Daren Tang
21 April 2026
The South Centre looks forward to a further engagement of WIPO Director General Daren Tang during his second term with the development dimension of intellectual property.
In our statement to the WIPO Assemblies on 21 April, we highlight priorities that should be included in the new Medium-Term Strategic Plan. These include: prioritize development, technology transfer, fee reductions for developing countries and LDCs, and a broader focus on innovation, not only on the role of IP.
Pending the Moratorium: the Status of Non-Violation and Situation Complaints Under the TRIPS Agreement Following MC14
By Viviana Munoz Tellez, Nirmalya Syam
The 14th WTO Ministerial Conference (MC14), held in Yaoundé, Cameroon, concluded on 30 March 2026 without extending the moratorium on non-violation and situation complaints (NVSCs) under the Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS Agreement). This policy brief argues that the expiry of the moratorium does not render NVSCs automatically applicable to disputes under the Agreement. The requirement under Article 64.3 for the TRIPS Council to examine the scope and modalities of NVSCs and for the WTO Ministerial Conference to adopt a consensus decision thereon, has not been fulfilled.
Until such a decision is taken, NVSCs remain inapplicable to TRIPS disputes. However, unless the implications of the non-extension are addressed, it may discourage the adoption of measures in the public interest by developing countries and least developed countries (LDCs) which would be fully legitimate under the TRIPS Agreement. Any attempt to suggest that NVSCs are now applicable to the obligations under this Agreement in the interim should be firmly contested. Resolving this issue through continued discussions in the TRIPS Council must be prioritized.
Access to Medicines and Intellectual Property: taking advantage of TRIPS flexibilities for post-COVID-19 resilience in Africa
By Ismaelline Eba Nguema
The call by India and South Africa for the provisional lifting of patents on pharmaceutical products has had the merit of putting the issue of access to medicines and public health back on the agenda. However, the difficulty of reconciling access to medicines and intellectual property has many factors which cannot be reduced solely to the commitments of WTO member states. A more in-depth analysis reveals the intrinsic limitations of some of its members. These include the weakness of the legislative and regulatory framework in some countries, such as those on the African continent. Consequently, the aim of this article is to demonstrate that effective use of the flexibilities in the TRIPS Agreement is only possible if African countries equip themselves with an appropriate legal framework, in addition to the judicial institutions that are supposed to guarantee the effectiveness of the standards adopted. The methodology used consisted of an exegesis of various documents, including articles, working documents of the TRIPS Council, declarations and resolutions of various bodies, as well as the national case law of certain WTO members, etc. This method led us to conclude that the compatibility between access to medicines and intellectual property is caught between human rights and economic interests. However, for the TRIPS flexibilities to be fully utilized by African countries, they would benefit from reforming their legal frameworks to take advantage of the flexibilities in the TRIPS Agreement.
Addressing Barriers to Accessing Monoclonal Antibodies (mAbs) in Developing Countries: Challenges and Potential Solutions
By Nirmalya Syam
Monoclonal antibodies (mAbs) have revolutionized treatment in oncology, autoimmune disorders, and infectious diseases due to their high specificity and efficacy. However, access to mAbs in developing countries remains severely limited due to high costs, market concentration in high-income regions, regulatory hurdles, and intellectual property barriers. Despite the potential of biosimilars to enhance affordability, their availability remains restricted due to expensive development processes, patent thickets, and complex regulatory requirements. The dominance of multinational pharmaceutical companies in the market further restricts competition, delaying biosimilar approvals and preventing price reductions. Additionally, regulatory agencies in developing countries often lack the resources to expedite biosimilar approvals, further exacerbating delays in access.
Policy interventions such as improved regulatory harmonization, stricter patent examination guidelines, and expanded public investment in mAb production are necessary to address these barriers. The adoption of the revised 2022 WHO Similar Biotherapeutic Products (SBP) Guidelines could streamline biosimilar approval by reducing unnecessary comparative clinical trials. Moreover, technology transfer initiatives and market-shaping incentives, including compulsory licensing, could help lower costs and accelerate the availability of mAbs in underserved regions.
By implementing these strategies, developing countries can bridge the access gap, ensuring that lifesaving mAb therapies reach the patients who need them most. A coordinated global effort involving policymakers, regulators, and industry stakeholders is essential to establishing a sustainable and equitable mAb supply chain.
Balancing the Global Copyright System in the Public Interest: An Analysis of the African Group’s Proposed Instrument on Limitations and Exceptions
By Faith O. Majekolagbe
The establishment of an international instrument on copyright limitations and exceptions (L&Es) is essential to achieve an appropriate balance between exclusive rights and the overarching public interest in access to copyrighted works and related subject matter. Current international copyright instruments, including the Marrakesh Treaty to Facilitate Access to Published Works for Persons Who Are Blind, Visually Impaired or Otherwise Print Disabled, fail to adequately address L&Es for education, research, equitable access for persons with disabilities, and the operations of educational, research, and cultural heritage institutions such as libraries, archives, and museums. The proposed instrument on L&Es by the African Group seeks to establish mandatory minimum L&Es to support education, research, and access to information within the international copyright system, thereby promoting global harmonization and ensuring that copyright law supports, not impedes, development objectives and human rights obligations. This policy brief offers a thorough analysis of the proposed instrument, examining its substantive provisions and potential benefits, and proposes some improvements.
WTO arbitration on China’s standard patents policy threatens TRIPS balance and national autonomy
By Nirmalya Syam
This article critically examines the WTO arbitration award in China – Enforcement of Intellectual Property Rights (WT/DS611/ARB25), which marks a significant departure from established interpretations of Article 1.1 of the Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS). The arbitrators endorsed a broad “anti-frustration” reading of the provision, effectively imposing cross-border obligations on WTO Members and challenging the autonomy of national courts. Although Article 1.1 of TRIPS was relied upon by the European Union only in conjunction with Article 28, the arbitrators treated it as an autonomous normative foundation for imposing cross-border constraints on members’ judicial measures. The article contends that this expansion of Article 1.1 goes beyond its text and structure, risks undermining legitimate public-interest measures, and opens the door to non-violation type complaints that are excluded from TRIPS. The analysis underscores the need to preserve the balance between IP enforcement and national policy space, especially in disputes involving public policy considerations.
Analysis of Intellectual Property Issues Ahead of the WTO 14th Ministerial Conference
By Nirmalya Syam, Viviana Munoz Tellez
This policy brief analyses the issues pertaining to the World Trade Organization (WTO) Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement) that were discussed in the General Council meeting on 16-17 December 2025. Despite the strategic importance of these issues, the divergence on TRIPS issues and on the priorities for the future work of WTO among Members did not allow the General Council to decide on any of these matters. None of the issues were noted for decision in the 14th Ministerial Conference (MC14), which is scheduled to be hosted in Yaoundé, Cameroon in March 2026. This reluctance of some Members to engage substantively on intellectual property (IP) issues has become a regular dynamic in the TRIPS Council. However, the MC14 should, at the least, decide to extend the moratorium on TRIPS Non-Violation and Situation Complaints and extend the period for acceptances by Members of the Protocol Amending the TRIPS Agreement. Moreover, there is an understanding that all issues remain on the table, regardless of whether they are taken up at the Conference.
The Golden Flower and the Blue Diamond: From Patent Law to Biodiversity Regimes and Guidelines
By Leïla Mamoni
In 2010, at the World Intellectual Property Organization (WIPO), an Intergovernmental Committee started its negotiations that notably aim at protecting traditional knowledge from fraudulent patents. On that same year, French company Chanel Parfums Beauté committed itself to combatting this monopolization that encroaches on the public domain. With a limited scope, this research paper examines this initiative and looks into two patent applications that the company withdrew. It also raises questions pertaining to the biodiversity regime or guidelines of the countries where the bioprospection was conducted, namely India and Madagascar. While the adoption of the WIPO Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge marks a significant step, both examples remind us of the difficulty of establishing a fraudulent intent, as provided for in the treaty. To address that difficult task, this paper suggests that countries with limited administrative capacities may consider the possibility of relying on South-South cooperation.
